Synedica Retatrutide review — 7 critical facts in 2026.

This Synedica Retatrutide review gives you the honest picture before you buy: what the product is, what the science does and doesn’t show, and how to check what you’re getting. We sell Synedica, so this Synedica Retatrutide review is clear about the limits as well as the strengths.

Every trial figure in this Synedica Retatrutide review comes from Eli Lilly’s TRIUMPH-1 announcement. Those results apply to Lilly’s investigational drug, not to any research-grade brand.

What is Synedica Retatrutide?

Synedica Retatrutide is a research-grade retatrutide product supplied as a 40mg pen. Synedica is a peptide brand, and it is not made by or connected to Eli Lilly.

Retatrutide itself (development code LY3437943) is a triple agonist. It acts on GIP, GLP-1 and glucagon receptors, where Mounjaro acts on two and Wegovy on one.

That triple action is why retatrutide gets so much attention, and why searches for a Synedica Retatrutide review keep growing. For the full science, read our overview of retatrutide in 2026.

Synedica Retatrutide review: 7 critical facts

These are the seven points we think matter most. Each one shapes the verdict at the end of this Synedica Retatrutide review.

1. It’s a research peptide, not an approved medicine

Retatrutide hasn’t been approved anywhere yet. Lilly is expected to file with the FDA first, and UK approval is unlikely before 2028.

Any honest Synedica Retatrutide review has to start here. There’s no MHRA oversight of research peptides in the way there is for licensed medicines.

2. The headline results belong to Lilly’s trial

In TRIUMPH-1, people on 12mg of Lilly’s retatrutide lost an average of 28.3% of their body weight over 80 weeks. In an extension for people with a BMI of 35 or more, that reached 30.3% at 104 weeks.

Those results came from a controlled trial with clinical-grade drug and medical supervision. No Synedica Retatrutide review can promise the same outcome from a research product.

3. Verification is the main quality signal

Every order from Mymetabolism includes a batch-specific certificate of analysis. It shows the tested purity and the batch it applies to.

In this Synedica Retatrutide review, that certificate is the single most important thing to check. We explain how in the section on genuine products below.

4. The pen format is convenient

Synedica comes as a 40mg pen rather than a vial that needs mixing. That removes a step many people find fiddly and reduces the chance of errors when preparing it.

Convenience scores well in this Synedica Retatrutide review. Pen formats are a big reason people choose Synedica over vial-based brands.

5. Side effects follow the GLP-1 pattern

In trials, the most common side effects of retatrutide were stomach-related: nausea, diarrhoea, vomiting and constipation. They mostly appeared during dose increases.

Retatrutide trials also reported dysaesthesia, a tingling or skin sensitivity that appeared more often at higher doses. Any Synedica Retatrutide review should flag it, as it’s rarely seen with Mounjaro or Wegovy.

6. Stopping has consequences

As with every drug in this class, weight tends to return after stopping unless habits have changed. Our guide to what happens when you stop retatrutide covers this in detail.

That’s a planning point rather than a flaw, but this Synedica Retatrutide review would be incomplete without it.

7. Interactions still need checking

If you take other medicines, check for interactions before starting anything new. Our article on retatrutide and metformin is one example of what to look out for.

The final fact in this Synedica Retatrutide review is simple: tell your GP about everything you take.

Pros and cons

Here is the balance sheet from this Synedica Retatrutide review in one place.

Pros	Cons
Batch-specific certificate of analysis on every order	Not an approved medicine
Ready-to-use 40mg pen format	No regulator oversight of research peptides
Free UK shipping and 24/7 support	Trial results can’t be assumed for any research product
Triple agonist with strong trial data behind the compound	Stomach side effects and dysaesthesia reported in trials

On balance, this Synedica Retatrutide review finds a well-verified product with real limits that every buyer should understand.

Synedica vs other retatrutide brands

Synedica isn’t the only retatrutide brand sold in the UK. VLS (Vitality Life Science) and Alluvi Healthcare are the two names buyers most often compare it with.

Brands differ mainly in format, verification and support rather than the compound itself. Some sell vials that need mixing, while Synedica sells a ready-to-use pen.

When comparing, use the same checklist this Synedica Retatrutide review applies. Ask for a batch-matched certificate, check the labelling and make sure there’s a UK seller you can contact.

On those points, Synedica compares well in this Synedica Retatrutide review. The pen format and certificate on every order are the clearest advantages.

Price and value

Check the Synedica Retatrutide product page for the current price. When judging value, look beyond the headline figure.

Compare the cost per milligram, and check what’s included. A certificate on every batch, free shipping and support all add value that a cheaper listing may not offer.

This Synedica Retatrutide review rates value as fair for a verified product. A much cheaper pen with no certificate is not a saving, it’s a risk.

Storage and handling

Like other peptides, retatrutide is sensitive to heat. Keep your pen in the fridge at 2 to 8°C, in its box and away from the cooling element.

Never freeze it, and don’t use a pen that has been frozen or left somewhere hot. Keep a note of when you first used each pen.

Good storage protects what you’ve paid for, which is why this Synedica Retatrutide review includes it. Follow any storage instructions supplied with your batch.

How to check you’re getting genuine Synedica

Counterfeit and mislabelled peptides are a real risk. These checks are the practical core of this Synedica Retatrutide review.

• Match the batch: the batch number on the certificate must match the batch number on your pen
• Read the purity figure: the certificate should state the tested purity and the testing method
• Check the lab: the certificate should name the laboratory that tested the batch
• Check the seller: buy from a UK seller with a real address and a way to contact support
• Be wary of bargains: prices far below the market often mean an unverified product

If a seller can’t give you a batch-matched certificate, don’t buy. That’s the clearest red flag any Synedica Retatrutide review can give you.

What to expect after ordering

Orders ship free across the UK in discreet packaging. The certificate of analysis for your batch comes with the order, so you can check it as soon as the pen arrives.

Check the pen before you store it. The packaging should be sealed and undamaged, and the batch number should match the certificate exactly.

If anything doesn’t match, contact our support team before using the pen. Support is available 24/7, and we’d rather answer a question than have you guess.

That after-sale support is one of the reasons this Synedica Retatrutide review rates the buying experience well. Every point in this Synedica Retatrutide review can be checked by you, not just taken on trust.

Who it isn’t for

Retatrutide belongs to the same broad family as GLP-1 medicines, so the same cautions apply. This Synedica Retatrutide review would advise against it for:

• Anyone who is pregnant, breastfeeding or trying to conceive
• Anyone under 18
• People with a history of pancreatitis
• People with a personal or family history of medullary thyroid cancer or MEN2
• People with type 1 diabetes

If any of these apply, speak to your GP about licensed options instead. If you’re already on Wegovy and have stalled, our guide to a Wegovy plateau covers approved next steps.

Our verdict

Our Synedica Retatrutide review verdict is that Synedica is a well-presented, verified research product, not a substitute for a licensed medicine. Its strengths are the batch-matched certificate, the pen format and UK support.

Its limits are the ones every research peptide shares: no approval, no regulator oversight and no guarantee that trial results carry over. Go in with those facts clear and this Synedica Retatrutide review has done its job.

Diet still matters whatever you use, and our guide to intermittent fasting on GLP-1 is a good next read. You can also compare CagriReta or browse the full Mymetabolism shop.